These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1860625)

  • 1. The cephalic and gastric phases of gastric secretion during H2-antagonist treatment.
    Merki HS; Wilder-Smith CH; Walt RP; Halter F
    Gastroenterology; 1991 Sep; 101(3):599-606. PubMed ID: 1860625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gastric feeding on intragastric P(CO2) tonometry in healthy volunteers.
    Kolkman JJ; Groeneveld AB; Meuwissen SG
    J Crit Care; 1999 Mar; 14(1):34-8. PubMed ID: 10102722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.
    Merki HS; Halter F; Wilder-Smith CH
    Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a five-day test to predict the long-term effects of gastric antisecretory agents on serum gastrin in rats.
    Katz LB; Schoof RA; Shriver DA
    J Pharmacol Methods; 1987 Dec; 18(4):275-82. PubMed ID: 3695537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.
    Wilder-Smith CH; Halter F; Häcki W; Merki HS
    Br J Clin Pharmacol; 1992 May; 33(5):487-93. PubMed ID: 1524960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on vagal activation of gastric acid secretion in man.
    Stenquist B
    Acta Physiol Scand Suppl; 1979; 465():1-31. PubMed ID: 291298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of pirenzepine and ranitidine on the nocturnal intragastric pH in non-responders to ranitidine.
    Walker S; Klotz U; Bode JC
    Z Gastroenterol; 1990 Aug; 28(8):379-82. PubMed ID: 2275257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
    Londong W; Londong V; Ruthe C; Weizert P
    Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous infusion of ranitidine on intragastric acidity in fasting subjects: comparison with bolus or Gastrojet (pH-stat-adjusted) infusion.
    Thomson AB; Kirdeikis P; Simon K; Zuk L; Pinchbeck B; Wasarab-Rolland D; Kersey K
    Aliment Pharmacol Ther; 1993 Dec; 7(6):649-53. PubMed ID: 8161672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged influence of a meal on the effect of ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1984 May; 19(3):429-32. PubMed ID: 6330872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of fasting on 24-h gastric secretion of patients with duodenal ulcers resistant to ranitidine.
    Johnston DA; Wormsley KG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):471-9. PubMed ID: 2518860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucagon on vagally induced gastric acid secretion in humans.
    Loud FB; Holst JJ; Christiansen J; Rehfeld JF
    Dig Dis Sci; 1988 Apr; 33(4):405-8. PubMed ID: 3349886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The timing of evening meal and ranitidine administration--effects on patterns of 24 hour intragastric acidity.
    Orr WC; Finn AL; Allen M; Robinson MG; Wilson T
    Aliment Pharmacol Ther; 1988 Dec; 2(6):541-9. PubMed ID: 2979277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.